Clean Science Approves ₹4 Final Dividend and Confirms ₹2 Interim Payout at 23rd AGM

Market snapshot: At its 23rd Annual General Meeting (AGM) held on September 12, 2026, Clean Science and Technology Limited approved all resolutions, including a final dividend of ₹4 per share for FY26. Together with the previously paid interim dividend of ₹2 per share, this brings the total dividend payout for the financial year to ₹6 per share. The shareholders also approved key administrative resolutions, including director re-appointments and new appointments.

Data Snapshot

• The approved final dividend stands at ₹4 per share, representing 400% of the face value of ₹1.
• The confirmed interim dividend stands at ₹2 per share, representing 200% of the face value of ₹1.
• The company reported a consolidated revenue of ₹957 crore for the financial year ended March 31, 2026.
• Consolidated Profit After Tax (PAT) for the financial year ended March 31, 2026, was ₹230 crore.

What's Changed

• The total dividend payout remains at ₹6 per share for FY26, showing a stable distribution profile identical to the total ₹6 per share paid in FY25.
• The board successfully expanded the executive team by co-opting and confirming Krishnakumar Satyanarain Saboo as a Whole-time Director for a five-year term.

Key Takeaways

• Consistent Cash Return: By maintaining a ₹6 per share total payout, Clean Science demonstrates stable cash-flow generation capability.
• Administrative Compliance: All ordinary and special resolutions at the 23rd AGM passed with the required voting thresholds.
• Leadership Continuity: The confirmation of both Krishnakumar Ramnarayan Boob and Krishnakumar Satyanarain Saboo ensures operational leadership stability for manufacturing and scaling up new capacities.

SAHI Perspective

Clean Science and Technology is demonstrating corporate governance stability and cash-return discipline despite structural challenges in the global chemical landscape. Maintaining the total dividend payout at ₹6 per share reflects the company's solid balance sheet. Since legacy concentration is decreasing, leadership stability under the newly appointed directors will be crucial to execute the ongoing ramp-up of the Hindered Amine Light Stabilisers (HALS) vertical and validation of new performance intermediates.

Market Implications

The resolution approvals provide positive baseline support for investor sentiment, reinforcing corporate continuity. A stable dividend structure cushions downside volatility during chemical sector cycles. However, as the dividend growth remains flat YoY, the focus shifts to how effectively the company deploys capital into high-margin greenfield projects to drive earnings expansion in upcoming quarters.

Trading Signals

Market Bias: Bullish

Approval of the ₹4 final dividend completes a ₹6 total dividend payout for FY26, reinforcing operational cash strength. Combined with record consolidated Q1 FY27 revenue of ₹268.43 crore and new global partnerships, the intermediate structural growth outlook remains supportive.

Overweight: Specialty Chemicals

Trigger Factors:

• Final dividend payment execution scheduled for September 30, 2026.
• Capacity utilization ramp-up of the HALS Unit 4 facility toward optimal levels.
• Commercialization timeline progress of Performance Chemical 2 plants.

Time Horizon: Near-term (0-3 months)

Industry Context

The Indian specialty chemical space is balancing export headwinds and logistical disruptions with structural domestic market capture. Catalytic, clean-chemistry processes are allowing domestic leaders like Clean Science to defend margins against commodity imports. Technology transfer initiatives and high-value export collaborations represent the primary route to scaling higher up the global value chain.

Key Risks to Watch

• Logistical Constraints: Export shipping disruptions or container shortages can delay high-margin overseas sales.
• Raw Material Volatility: Unplanned domestic outages for key raw materials like propylene could impact near-term production margins.

Recent Developments

In Q1 FY27, Clean Science reported record-high consolidated sales of ₹268.43 crore, showing a 10.53% YoY growth. The board also approved the incorporation of Clean Science International B.V. as a wholly owned subsidiary in the Netherlands to manage European trading activities. Additionally, subsidiary Clean Fino-Chem Limited entered into a strategic co-branding and technology transfer collaboration with Geneus Chem AG in Switzerland.

Closing Insight

Clean Science and Technology's 23rd AGM underscores steady corporate governance. While dividend payouts remain stable, long-term valuation recovery will depend on capital deployment efficiency and execution of its international chemical supply tie-ups.

High Performance Trading with SAHI.